AASLD Abstracts
723 Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir

https://doi.org/10.1016/S0016-5085(13)63564-7Get rights and content

References (0)

Cited by (0)

View full text